CRL

#978
Charles River Laboratories International, Inc.
179.2500 USD
+0.97%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
179.2500
180.4400
Rango anual
146.4900
228.8800
Cambio diario
+0.97%
Variación mensual
+13.85%
Variación en los últimos 6 meses
-8.94%
Cambio anual
-8.94%
Cierres anteriores
177.5350
Abrir
180.2400
Bid
Ask
Mínimo
179.2500
High
180.4400
Volumen
305
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 8.8241 B
  • Employee 20 K
  • Founded N/A
  • CEO James C. Foster
  • Website www.criver.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000BG5BL8
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-69.81
Relación precio/flujo de caja
2.51

Charles River Laboratories International Inc

Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients. Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs. As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL.

Noticias